VCNX: Vaccinex Inc Company Profile & Statistics

About

Vaccinex, Inc. is a clinical-stage immunotherapy company. It engages in the discovery and development of biotherapeutics to treat serious diseases and conditions with unmet medical needs, including cancer, neurodegenerative diseases and autoimmune disorders. The company's product pipeline consists of VX15, VX5 and VX25 which are in clinical stage. Vaccinex, Inc. is based in Rochester, New York.

Info & Links

CEO

Maurice Zauderer

Headquarters

1895 MOUNT HOPE AVENUE
ROCHESTER, NY 14620, UNITED STATES

Auditor

Deloitte & Touche LLP

Share holders

144

Employees

Vaccinex Inc Statistics

Valuation Measures

Market Capitalization²

3.72M

Enterprise Value

856.00K

Enterprise Value/EBITDA(ttm)

-0.04

Price to Earnings Ratio(ttm)

Price to Sales(ttm)

Price to Book(mrq)

Price to Cash(ytd)

Profitability

Gross Margin(ttm)

75.00%

Operating Margin(ttm)

Profit Margin(ttm)

-4299.34%

Return on Equity(ttm)

Return on Invested Capital(ttm)

629.24%

Return on Assets(ttm)

-383.58%

Income Statement

Revenue(ttm)

388.00K

Revenue Per Share(ttm)

0.15

Gross Profit(ttm)

388.00K

EBITDA(ttm)³

-20.23M

Net Income Available to Common(ttm)

-18.58M

Diluted EPS(ttm)

-48.27

Share Statistics

Beta (5Y Monthly)

1.10

52-Week Change

-85.99%

S&P 500 52-Week Change

26.61%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding¹

2.60M

Dividend Yield

0.00%

Float⁴

1.26M

% Held by Insiders

51.50%

% Held by Institutions

50.11%

Balance Sheet

Total Cash(mrq)

2.91M

Total Cash Per Share(mrq)

1.12

Total Debt(mrq)

44.00K

Total Debt/Equity(mrq)

-3.33%

Current Ratio(mrq)

0.77%

Quick Ratio(mrq)

0.77%

Book Value Per Share(mrq)

-0.51

Cash Flow

Operating Cash Flow Per Share(ytd)

-6.05

Free Cash Flow(ytd)

-12.28M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
2 Market Cap is calculated using total shares outstanding and the most recent share price.
3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

VCNX

Vaccinex Inc

Vaccinex Inc Profile